Abstract
Heparin and low molecular weight heparins are major clinical anticoagulants and the drugs of choice for the treatment of deep venous thrombosis. The discovery of an antithrombin binding domain in heparin focused interest on understanding the mechanism of heparins antithrombotic / anticoagulant activity. Various heparin-mimetic oligosaccharides have been prepared in an effort to replace polydisperse heparin and low molecular weight heparins with a structurally-defined anticoagulant. The goal of attaining a heparin-mimetic with no unwanted side-effects has also provided motivation for these efforts. This article reviews structure-activity relationship (SAR) of structurally-defined heparin-mimetic oligosaccharides.
Keywords: heparin, anticoagulant, antithrombotic, antithrombin III, heparin pentasaccharide, factor xa, thrombin, bisaldonic acid amides
Current Pharmaceutical Design
Title: Synthetic Oligosaccharides as Heparin-Mimetics Displaying Anticoagulant Properties
Volume: 9 Issue: 28
Author(s): Fikri Y. Avci, Nathalie A. Karst and Robert J. Linhardt
Affiliation:
Keywords: heparin, anticoagulant, antithrombotic, antithrombin III, heparin pentasaccharide, factor xa, thrombin, bisaldonic acid amides
Abstract: Heparin and low molecular weight heparins are major clinical anticoagulants and the drugs of choice for the treatment of deep venous thrombosis. The discovery of an antithrombin binding domain in heparin focused interest on understanding the mechanism of heparins antithrombotic / anticoagulant activity. Various heparin-mimetic oligosaccharides have been prepared in an effort to replace polydisperse heparin and low molecular weight heparins with a structurally-defined anticoagulant. The goal of attaining a heparin-mimetic with no unwanted side-effects has also provided motivation for these efforts. This article reviews structure-activity relationship (SAR) of structurally-defined heparin-mimetic oligosaccharides.
Export Options
About this article
Cite this article as:
Avci Y. Fikri, Karst A. Nathalie and Linhardt J. Robert, Synthetic Oligosaccharides as Heparin-Mimetics Displaying Anticoagulant Properties, Current Pharmaceutical Design 2003; 9 (28) . https://dx.doi.org/10.2174/1381612033453929
DOI https://dx.doi.org/10.2174/1381612033453929 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Prospecting for New Inhibitors of Anaplastic Lymphoma Kinase, A Clinically Relevant Oncogenic Drug Target
Current Bioactive Compounds Theoretical and Practical Considerations in Virtual Screening: A Beaten Field?
Current Medicinal Chemistry Combination of Hydroxychloroquine, Melatonin and Mercaptopurine as a Possible Intervention for Prophylaxis and Treatment of Novel COVID-19 Infection
Coronaviruses Fatty Acid Biosynthesis: An Updated Review on KAS Inhibitors
Current Drug Discovery Technologies Enzyme Inhibitors
Current Bioactive Compounds Cholesteryl Ester Transfer Protein: Pharmacological Inhibition for the Modulation of Plasma Cholesterol Levels and Promising Target for the Prevention of Atherosclerosis.
Current Topics in Medicinal Chemistry Discovery of AX8312, an N-alkyl-Gly-boro-Pro Derivative that Accelerates Recovery from Neutropenia in the Mouse
Letters in Drug Design & Discovery Nanomaterials of Natural Bioactive Compounds for Wound Healing: Novel Drug Delivery Approach
Current Drug Delivery A Composite Study of Coagulation Milieu in Covid-19: Experience from a Tertiary Care Centre from India
Cardiovascular & Hematological Disorders-Drug Targets Synthesis, Nematicidal Activity and Docking Study of Novel Pyrazole-4-Carboxamide Derivatives Against Meloidogyne incognita
Letters in Drug Design & Discovery Neuroprotective Activities of Marine Natural Products from Marine Sponges
Current Medicinal Chemistry Computer Aided Drug Design: Success and Limitations
Current Pharmaceutical Design Rational Design of Antimalarial Drugs Using Molecular Modeling and Statistical Analysis
Current Pharmaceutical Design Impact of COVID-19 Pandemic on Cardiology Resident Training and Education
New Emirates Medical Journal COVID-19 and Diabetes Mellitus: Potential Metabolic Associations
Current Topics in Medicinal Chemistry Plant-Derived Natural Compounds for the Treatment of Amyotrophic Lateral Sclerosis: An Update
Current Neuropharmacology Prevention and Treatment of Cardiovascular Disease in Adolescents and Adults through the Transcendental Meditation® Program: A Research Review Update
Current Hypertension Reviews Rheumatoid Nodules and Lung
Current Respiratory Medicine Reviews Recent Advances in Small-Molecule HIV-1 Integrase Inhibitors
Current Medicinal Chemistry Synthesis and Bioactivities of 2-Azetidinones as Cholesterol Absorption Inhibitors
Letters in Drug Design & Discovery